Edoardo Ruggeri (Edoardo Ruggieri)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Protein Protein

Chronic Lymphocytic Leukemia

Drug Administration

Top Venues

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Federica Frezzato, Andrea Visentin, Filippo Severin, Serena Pizzo, Edoardo Ruggeri, Nayla Mouawad, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Alessia Tonini, Samuela Carraro, Stefano Pravato, Silvia Imbergamo, Sabrina Manni, Francesco A Piazza, Anna Maria Brunati, Monica Facco, Livio Trentin
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. Cancers 13 (21) (2021)
Andrea Visentin, Federica Frezzato, Filippo Severin, Silvia Imbergamo, Stefano Pravato, Leila Romano Gargarella, Sabrina Manni, Serena Pizzo, Edoardo Ruggeri, Monica Facco, Anna Maria Brunati, Gianpietro Semenzato, Francesco A Piazza, Livio Trentin
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia. OncoTargets and therapy 13 (2020)